Exploring continuous and integrated strategies for the up- and downstream processing of human mesenchymal stem cells
- 1 November 2015
- journal article
- Published by Elsevier in Journal of Biotechnology
- Vol. 213, 97-108
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e Tecnologia
- NanoGene project
This publication has 26 references indexed in Scilit:
- Filtration methodologies for the clarification and concentration of human mesenchymal stem cellsJournal of Membrane Science, 2015
- Long Term Expansion of Bone Marrow-Derived hMSCs on Novel Synthetic Microcarriers in Xeno-Free, Defined ConditionsPLOS ONE, 2014
- A xenogeneic‐free bioreactor system for the clinical‐scale expansion of human mesenchymal stem/stromal cellsBiotechnology and Bioengineering, 2014
- Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future directionBiotechnology Advances, 2013
- Continuous downstream processing of biopharmaceuticalsTrends in Biotechnology, 2013
- Toward a Clinical-Grade Expansion of Mesenchymal Stem Cells from Human Sources: A Microcarrier-Based Culture System Under Xeno-Free ConditionsTissue Engineering Part C: Methods, 2011
- Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potentialBiology of the Cell, 2011
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chlorideToxicology Letters, 2006
- An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide.Journal of Histochemistry & Cytochemistry, 1985